Radiation plus concurrent nimotuzumab versus CDDP in locally advanced nasopharyngeal cancer: Results of a phase III randomised trial.

被引：7
|
作者：
Kong, Lin
Lin, Qin
Hu, Chaosu
Xu, Tingting
Liao, Xiyi
Shen, Chunying
Lu, Jiade J.
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Shanghai Proton & Heavy Ion Ctr, Shanghai, Peoples R China
[3] Xiamen Univ, Affiliated Hosp 1, Xiamen, Fujian, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.6002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6002
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Radiation Plus Concurrent Nimotuzumab Versus Cisplatin-Based Chemotherapy in Locally Advanced Nasopharyngeal Cancer: An Interim Analysis of a Phase 3 Randomized Clinical Trial
    Kong, L.
    Lin, Q.
    Hu, C.
    Xu, T.
    Liao, X.
    Shen, C.
    Zheng, H.
    Niu, X.
    Lu, J. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S129 - S129
  • [2] Nimotuzumab plus chemoradiotherapy versus placebo plus chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma (NPC): A prospective, randomized-controlled, double-blinded, multicenter phase III clinical trial.
    Sun, Yan
    Hu, Chaosu
    Lin, Qin
    Gao, Li
    Wang, Jianhua
    Zhu, Xiaodong
    Hao, Junfang
    Lang, Jin Yi
    Wang, Peiguo
    Ye, Ming
    Li, Xia
    Xu, Benhua
    Wu, Rong
    Bai, Chunmei
    You, Qingshan
    Chen, Xiaozhong
    Wang, Jun
    Hu, Desheng
    Wu, Gang
    Pan, Jian-Ji
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial.
    Chen, Ming-Yuan
    Cao, Su-Mei
    Yang, Qi
    Guo, Ling
    Mai, Hai-Qiang
    Mo, Hao-Yuan
    Cao, Ka-Jia
    Qian, Chao-Nan
    Zhao, Chong
    Yanqun, Xiang
    Zhang, Xiu-Ping
    Lin, Zhi-Xiong
    Li, Wei-Xiong
    Guo, Xiang
    Hong, Ming-Huang
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [4] A phase II study of nimotuzumab and CDDP concurrent with radiation in locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Lim, Wan-Teck
    Ang, Mei-Kim
    Quan Sing Ng
    Wang, Lan-Ying
    Chau, Noan-Minh
    Tan, Daniel S. W.
    Chay, Wen Yee
    Leong, Swan
    Tan, Eng-Huat
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] A randomized phase III trial of concurrent chemoradiotherapy in locally advanced cervical cancer: Preliminary results
    Veerasarn, Vutisiri
    Lorvidhaya, Vicharn
    Kamnerdsupaphon, Pimkhuan
    Suntornpong, Nan
    Sangruchi, Supatra
    Lertsanguansinchai, Prasert
    Khorprasert, Chonlakiet
    Sookpreedee, Lak
    Udompunturak, Suthipol
    GYNECOLOGIC ONCOLOGY, 2007, 104 (01) : 15 - 23
  • [6] A randomized phase III trial of concurrent chemoradiation in locally advanced cervical cancer: preliminary results
    Veerasarn, V.
    Lorvidhaya, V.
    Suntornpong, N.
    Sukthomya, V.
    Sangruchi, S.
    Chitapanarux, I.
    Lertsanguansinchai, P.
    Khorprasert, C.
    Sookpreedee, L.
    Udompunturak, S.
    EJC SUPPLEMENTS, 2005, 3 (02): : 260 - 260
  • [7] Low-Dose Fractionated Radiation with Induction Docetaxel and Cisplatin Chemotherapy followed by Concurrent Cisplatin and Radiation Therapy in Locally Advanced Nasopharyngeal Cancer, Randomized Phase II-III Trial.
    Al-Rajhi, N. M.
    Abdelrahman, E. M.
    Ahmad, S.
    Soudy, H.
    AlGhazi, M.
    Al Shabanah, M. O.
    Memon, M.
    Khafaga, Y. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E387 - E387
  • [8] Prospective phase II trial of nimotuzumab in combination with radiotherapy and concurrent capecitabine in locally advanced rectal cancer
    Jin, Ting
    Zhu, Yuan
    Luo, Jia-Lin
    Zhou, Ning
    Li, De-Chuan
    Ju, Hai-Xin
    Fan, Yong-Tian
    Liu, Yong
    Zhu, Yu-Ping
    Feng, Hai-Yang
    Liu, Lu-Ying
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2015, 30 (03) : 337 - 345
  • [9] Prospective phase II trial of nimotuzumab in combination with radiotherapy and concurrent capecitabine in locally advanced rectal cancer
    Ting Jin
    Yuan Zhu
    Jia-Lin Luo
    Ning Zhou
    De-Chuan Li
    Hai-Xin Ju
    Yong-Tian Fan
    Yong Liu
    Yu-Ping Zhu
    Hai-Yang Feng
    Lu-Ying Liu
    International Journal of Colorectal Disease, 2015, 30 : 337 - 345
  • [10] Nimotuzumab plus induction chemotherapy followed by radiotherapy/concurrent chemoradiotherapy plus nimotuzumab for locally advanced nasopharyngeal carcinoma: protocol of a multicentre, open-label, single-arm, prospective phase II trial
    Yuan, Jing-Jing
    Ding, Jian-Wu
    Li, Jin-Wei
    Hu, Rong-Huan
    Gong, Dan
    Hu, Jia-Li
    Zhu, Kai-Bin
    Liu, Yan
    Ding, Yu-Hai
    Wei, Jia-Wang
    Zeng, Jian-Lun
    Lu, Zhi-Bing
    Yin, Wei-Hua
    Ai, Su-Fen
    Zha, Guo-Hua
    Zhang, Zhi-Lin
    Zou, Rui
    Zeng, Lei
    BMJ OPEN, 2022, 12 (08):
12345